What is Friedman Levy?
Friedman Levy, formally known as Friedman, Levy, Goldfarb, Green & Bagley, P.C., occupies a critical niche in the personal injury sector. By operating on a contingency-fee basis—often referred to as a no win, no fee model—the firm lowers the barrier to entry for clients seeking justice against negligence. Their market position is defined by a high-volume, high-stakes approach to medical malpractice and personal injury law, supported by a proven track record of securing substantial verdicts and settlements for their clientele. The firm's operational strategy relies on deep expertise in tort law and a client-centric service model that prioritizes personalized representation.
How much funding has Friedman Levy raised?
Friedman Levy has raised a total of $345K across 2 funding rounds:
Debt
$150K
Debt
$195K
Debt (2020): $150K with participation from PPP
Debt (2021): $195K led by PPP
Key Investors in Friedman Levy
PPP
Public-Private Partnership
What's next for Friedman Levy?
With the infusion of this recent capital, Friedman Levy is well-positioned to enhance its litigation infrastructure and expand its outreach capabilities. In the context of late-stage development, such financing typically serves to optimize case management workflows, invest in advanced legal research technologies, and potentially increase the firm's capacity to handle complex, high-value litigation. As the firm continues to navigate the evolving landscape of New York tort law, this strategic backing provides the necessary liquidity to sustain long-term growth and maintain its competitive edge in securing maximum compensation for injured parties.
See full Friedman Levy company page
